Characterization of the genotypes of patients with Gaucher disease type 1 in the Russian Federation


Cite item

Full Text

Abstract

AIM: To characterize the genotype and genotype-phenotype correlations in patients with Gaucher disease (GD) in the Russian Federation. Materials and methods. One hundred adult patients with GD type 1 were examined. Their clinical study encompassed the evaluation of the severity of osteoarticular lesions from instrumental findings. An allele-specific real-time polymerase chain reaction assay was used to screen four most common acid Β-glucoside gene (GBA) mutations (N370S, 84GG, L444P, IVS2+1)/RESULTS: The N370S mutation and the N370S/? genotype where the second allele was presented with the mutation outside the 4 most common GBA gene mutations were found in the Russian patients with GD. Analysis of the clinical manifestations of the disease revealed no association between the genotype under examination and the severity of osteoarticular lesions and supported the unfavorable role of splenectomy (SE) in the development of severe bony disease/CONCLUSION: SE should be carried out in patients with unclear cytopenia and splenomegaly after the diagnosis of GD is excluded. The GD patients undergoing SE should receive emergency enzyme replacement therapy to prevent severe osteoarticular lesions and an irreversible orthopedic defect.

About the authors

K A Lukina

Гематологический научный центр Минздрава России, Москва

I S Fevraleva

Гематологический научный центр Минздрава России, Москва

E P Sysoeva

Гематологический научный центр Минздрава России, Москва

V E Mamonov

Гематологический научный центр Минздрава России, Москва

A B Sudarikov

Гематологический научный центр Минздрава России, Москва

E A Lukina

Гематологический научный центр Минздрава России, Москва

References

  1. Futerman A.H. ed., Zimran A. ed. Gaucher disease. Boca Raton: Taylor & Francis Group. LLC 2007.
  2. Christomanou H., Aignesberger A., Linke R.P. Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant. Biol Chem Hoppe Seyler 1986; 367 (9): 879-890.
  3. Тотолян А.А., Фрейдлин И.С. Клетки иммунной системы. СПб: Наука 2000.
  4. Лукина Е.А. Болезнь Гоше. М: Литтерра 2011.
  5. Mistry P.K., Cox T.M. The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme. J Med Genet 1993; 30 (11): 889-894.
  6. Grabowski G.A. Gaucher disease and other storage disorders. In: Hematology 2012: 54th ASH Annual Meeting and Exposition. Atlanta, Georgia, 2012: 13-18.
  7. Mankin H.J., Rosenthal D.I., Xavier R. Gaucher disease. New approaches to an ancient disease. J Bone Joint Surg Am 2001; 83-A (5): 748-762.
  8. Gaucher Registry Annual Report, 2009. Доступно на https://www.registrynxt.com/Gaucher/Pages/Home.aspx
  9. Beutler E., Demina A., Gelbart T. Glucocerebrosidase mutations in Gaucher disease. Mol Med 1994; 1 (1): 82-92.

Copyright (c) 2013 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies